Short answer
Septerna, Inc. (SEPN) filed its Q3 2025 10-Q quarterly report on Nov 10, 2025 for the quarter ended Sep 30, 2025. Quarterly revenue was $21M (up 2390.7% year over year) with net income of $8M.
Q3 2025 key financials · XBRL
- Revenue
- $21M
- +2390.7% YoY · +17963.0% QoQ
- Net income
- $8M
- +116.0% YoY · +132.9% QoQ
- Operating margin
- 12.2%
- EPS (diluted)
- $0.19
- +100.9% YoY · +133.9% QoQ
Source: XBRL data from the Septerna, Inc. (SEPN) Q3 2025 10-Q on SEC EDGAR. USD.
Septerna, Inc. Q3 2025 10-Q analysis
AI summary of MD&A and risk factor updates
Risk Factors
- No explicit quarter-specific risk-factor changes provided; supplied excerpt is truncated before the Risk Factors section
- Liquidity risk: accumulated deficit $156.5 million despite $561.6 million in cash, cash equivalents, and marketable securities
- Financing risk: additional funding required, potentially on unacceptable terms or unavailable
- Regulatory risk: no product candidate approved by the FDA for commercial sale
- Collaboration risk: revenue depends on Novo and Vertex upfront payments and milestone achievements
Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K
Other Septerna, Inc. quarterly reports
Ask about this quarter
Compare quarters, check guidance or see what insiders and funds did around the report.